Midgard Science

Nuvisan

Neu-Ulm, Germanynuvisan.comFrom their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Nuvisan provides contract research and development services for drug discovery, preclinical development, clinical trials, and clinical trial supply. It serves pharmaceutical and biotech clients from sites in Germany, France, and India.

Services

  • Omics and biomarkers

    Supports target identification and validation, mode-of-action studies, compound profiling, and pharmacodynamic and predictive biomarker discovery.

  • Functional genomics and next-generation sequencing

    Provides CRISPR/Cas9, RNA interference, NGS, single-cell sequencing, and bioinformatics for functional studies and target discovery.

  • Biosciences

    Offers protein production, biochemical assays, cell-based assays, high-content analysis, biophysics, mass spectrometry, and structural biology support for hit identification and characterisation.

  • Compound screening

    Runs high-throughput screening to identify first hits against client-specific targets and mechanisms.

  • Pharmacology

    Delivers in vivo pharmacology models to generate efficacy and safety data for drug development.

  • Chemistry

    Supports hit-to-lead, lead optimisation, scale-up, biotransformations, and physicochemical characterisation.

  • Development DMPK

    Provides in vitro and in vivo DMPK and ADME services, metabolite identification, isotope chemistry, and bioanalysis.

    ADME, DMPK & toxicology

  • In vitro DMPK

    Performs assays for metabolic stability, drug-drug interactions, metabolite identification, permeability and transporters, and protein binding.

    ADME, DMPK & toxicology

15 more services
  • Metabolite ID
  • Preclinical development
  • Clinical services phase 1-2
  • Clinical pharmacology unit
  • Clinical laboratory
  • Clinical trial supply services
  • Manufacturing of IMP
  • Digital science technologies
  • Cheminformatics and machine learning
  • Discovery services
  • Pharmaceutical analytical services
  • Drug substances
  • Drug products
  • Bioanalysis
  • Biomarkers
What to send
Sample barcoding

Capabilities

Assays and studies
  • Bioanalysis
  • Stability studies
  • CRISPR
  • ADME
  • Toxicology
  • In vivo
21 more
  • HTS
  • Small molecules
  • High-throughput screening
  • Biochemical assays
  • Cell-based assays
  • High-content assays
  • Biophysics assays
  • Protein binding assays
  • Drug-drug interaction assays
  • Metabolic stability assays
  • Permeability assays
  • Transporter assays
  • Metabolite identification
  • In vivo efficacy studies
  • PK/PD studies
  • Clinical safety lab analyses
  • Fragment screening
  • Virtual screening
  • Biophysical analyses
  • Structure-based design
  • CRISPR/Cas9
Scale and capacity
  • 40 high-monitoring beds
  • 60 overnight beds
  • Up to 100 L fermenters
  • 4-16 L wave bioreactors
  • Semi-solid clinical batches up to 50 kg
  • Proprietary small molecule library up to 3 million compounds
3 more
  • More than 5.000 m² GMP facilities
  • More than 320 m² of stability storage
  • Six full-time qualified persons
Therapeutic areas
  • Oncology
  • Dermatology

Instruments and platforms

  • 10x Genomics
  • ClinSpark
  • ÄKTA
  • SPR
  • MST
  • ITC
  • NMR
  • nanoDSF
  • TSA
  • SEC-MALS
  • DLS
  • F-SEC
  • Flow cytometry
  • MS
  • HR-MS
  • Electronic lab notebook
  • LIMS

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • ADC
  • Peptide
  • Gene editing
  • Recombinant protein
  • Vaccine
  • Biosimilar
Species and models
  • Rodent
  • Non-rodent species
  • Healthy volunteers
  • Special populations
  • Patients
  • iPSC-derived cells
11 more
  • Primary cells
  • Cell lines
  • E. coli
  • Insect cells
  • Mammalian cells
  • CHO
  • HEK293
  • Expi293F
  • Tni
  • Tumour-bearing animal models
  • In vivo models

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

  • GLPSelf-reported

    Scope: laboratories

Details

Type
CRDMO
Team
More than 100 analytical experts across Europe
Address
Wegenerstrasse 13 89231 Neu-Ulm Germany Berlin Muellerstrasse 178 13353 Berli
Sites
Berlin, Germany · Sophia Antipolis, France · Grafing, Germany · Waltrop, Germany · Hyderabad, India
Serves
Global, worldwide, Europe

Public records

Parent company
Nuvisan ICB GmbH · DE GLEIF
FDA drug establishment registration
3002809479 · ANALYSIS source

Similar labs